Parallel Advisors, LLC Seagen Inc. Transaction History

Parallel Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	BUY	$191.51 - $216.16 $3,255 - $3,674	17 Added 9.09%	204 $43,000
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $3,255 - $3,674	17 Added 9.09%	204 $43,000
Q2 2023 May 20, 2024	BUY	$187.64 - $206.25 $1,125 - $1,237	6 Added 3.31%	187 $35,000
Q2 2023 Aug 04, 2023	BUY	$187.64 - $206.25 $1,125 - $1,237	6 Added 3.31%	187 $35,000
Q1 2023 May 20, 2024	BUY	$127.59 - $203.08 $23,093 - $36,757	181 New	181 $36,000
Q1 2023 Apr 25, 2023	BUY	$127.59 - $203.08 $8,803 - $14,012	69 Added 61.61%	181 $36,000
Q4 2022 Feb 03, 2023	SELL	$117.37 - $139.17 $8,098 - $9,602	-69 Reduced 38.12%	112 $14,000
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $10,686 - $14,228	-79 Reduced 30.38%	181 $25,000
Q2 2022 Aug 01, 2022	SELL	$108.81 - $179.33 $4,787 - $7,890	-44 Reduced 14.47%	260 $46,000
Q1 2022 Apr 28, 2022	SELL	$119.61 - $157.85 $1,913 - $2,525	-16 Reduced 5.0%	304 $43,000
Q4 2021 Jan 20, 2022	SELL	$142.57 - $190.86 $14,257 - $19,086	-100 Reduced 23.81%	320 $49,000
Q3 2021 Nov 02, 2021	BUY	$142.45 - $169.82 $12,535 - $14,944	88 Added 26.51%	420 $71,000
Q2 2021 Aug 06, 2021	BUY	$135.08 - $161.1 $2,161 - $2,577	16 Added 5.06%	332 $52,000
Q1 2021 Apr 23, 2021	SELL	$137.51 - $190.8 $22,826 - $31,672	-166 Reduced 34.44%	316 $44,000
Q4 2020 Feb 02, 2021	BUY	$164.63 - $211.93 $79,351 - $102,150	482 New	482 $84,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.